Innovation1 Biotech Stock

Innovation1 Biotech Debt

The Debt of Innovation1 Biotech (IVBT) as of Aug 19, 2026 is 179,100.00 USD. In the previous year, Debt was -146,500.00 USD — a change of -222.25% (higher).

Debt

179,100.00USD

YoY

-222.25%

Last updated:

In 2026, Innovation1 Biotech's total debt was 179,100.00 USD, a -222.25% change from the -146,500.00 USD total debt recorded in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Innovation1 Biotech Stock analysis

What does Innovation1 Biotech do? Innovation1 Biotech is one of the most popular companies on Eulerpool.

Debt Details

Understanding Innovation1 Biotech's Debt Structure

Innovation1 Biotech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Innovation1 Biotech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Innovation1 Biotech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Innovation1 Biotech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Innovation1 Biotech stock

Debt of Innovation1 Biotech is 179,100.00 USD in 2026.

Debt of Innovation1 Biotech changed from -146,500.00 USD to 179,100.00 USD, representing a -222.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Innovation1 Biotech since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Innovation1 Biotech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Innovation1 Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Innovation1 Biotech